Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration

NCT01566006 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Nephropathy
Chronic Kidney Disease

Interventions

DRUG: Mycophenolate Mofetil (MMF) ,phosphodiesterase 5 inhibitors , CARNITINE

Sponsor

The Nazareth Hospital, Israel

Collaborators

[object Object]